Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies
J. Pathol.; 226: 132–142. 2012 Jan; doi: 10.1002/path.2984.
Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease
The Journal of Biological Chemistry 287, 3842-3849. doi: 10.1074/jbc.M111.277061
Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease
Cell 2012 Mar 30;149(1):232-44. doi: 10.1016/j.cell.2012.02.016
Nanopore Analysis: An emerging technique for studying the folding and misfolding of proteins
Prion; 2012 Apr 1;6(2):116-23. Epub 2012 Apr 1.pp 116-123 DOI /10.4161/pri.18665
Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models
Neurobiol Aging. 2013 Jan;34(1):338-50. doi: 10.1016/j.neurobiolaging.2012.05.010
Constitutive secretion of tau protein by an unconventional mechanism
Neurobiol Dis 2012 Dec;48(3):356-66. doi: 10.1016/j.nbd.2012.05.021. Epub 2012 Jun 2
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies
Journal of Neurochemistry; https://doi.org/10.1111/j.1471-4159.2012.07911.x.
Methods for Measuring Tau Pathology in Transgenic Mouse Models
Journal of Alzheimer’s Disease; DOI 10.3233/JAD-2012-121354
A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of A 38, A 40, and A 42 in Cerebrospinal Fluid of Alzheimer’s Disease Patients and Healthy Controls
Journal of Alzheimer’s Disease; DOI: 10.3233/JAD-2012-121471.
α-Synuclein potentiates interleukin-1β-induced CXCL10 expression in human A172 astrocytoma cells
Neuroscience Letters; Volume 507, Issue 2, 24 January 2012, Pages 133–136 DOI:10.1016/j.neulet.2011.12.001.